Literature DB >> 6688504

Retinal damage from a Q-switched YAG laser.

L M Jampol, M F Goldberg, N Jednock.   

Abstract

A 42-year-old woman with sickle cell anemia and proliferative retinopathy underwent neodymium-YAG laser therapy for a taut posterior hyaloid membrane causing peripapillary and peripheral traction detachment of the retina. Vitrectomy was not done because the patient required anticoagulation. A Q-switched YAG laser was capable of cutting holes in the taut membrane, but treatment 2 to 3 mm from the retina resulted in microperforation of a retinal vein and focal areas of damage to the retinal pigment epithelium. The damage to the retinal pigment epithelium was not immediately apparent, and ophthalmoscopically visible lesions were seen only when the patient was reexamined 48 hours later.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688504     DOI: 10.1016/s0002-9394(14)77823-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Nd-YAG laser treatment in preretinal macular fibrosis.

Authors:  M J Tassignon; M Brihaye; N Stempels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

2.  Corneal endothelial damage after Nd:YAG laser anterior capsulotomy. An experimental study on rabbits.

Authors:  E Vaikoussis; Z Bisogiannis; L Margaritis
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

3.  Treatment of vitreous floaters with neodymium YAG laser.

Authors:  W F Tsai; Y C Chen; C Y Su
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

4.  Damage to the corneal endothelium during Nd/YAG photodisruption.

Authors:  M G Kerr Muir; E S Sherrard
Journal:  Br J Ophthalmol       Date:  1985-02       Impact factor: 4.638

5.  Retrohyaloid premacular hemorrhage treated by Q-switched Nd-YAG laser. A case report.

Authors:  M J Tassignon; N Stempels; L Van Mulders
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

6.  Nd:YAG laser hyaloidotomy for valsalva pre-macular haemorrhage.

Authors:  R P Kirwan; M T Cahill
Journal:  Ir J Med Sci       Date:  2009-06-03       Impact factor: 1.568

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

Review 8.  Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review.

Authors:  T Ivanova; A Jalil; Y Antoniou; P N Bishop; J L Vallejo-Garcia; N Patton
Journal:  Eye (Lond)       Date:  2016-03-04       Impact factor: 3.775

9.  [Vitreous body floaters and vitrectomy with full visual acuity].

Authors:  H Hoerauf; M Müller; H Laqua
Journal:  Ophthalmologe       Date:  2003-06-18       Impact factor: 1.059

Review 10.  Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.

Authors:  Andreas Katsanos; Nikoleta Tsaldari; Konstantina Gorgoli; Fotios Lalos; Maria Stefaniotou; Ioannis Asproudis
Journal:  Adv Ther       Date:  2020-02-21       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.